ProCE Banner Activity

NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon

Slideset Download
Conference Coverage
Both DTG 50 mg plus 3TC/TDF and EFV 400 mg plus 3TC/TDF regimens effective and safe for treatment-naive PWH in Cameroon, with higher rates of virologic suppression over time and more weight gain observed with DTG-based regimen.

Released: August 02, 2022

Expiration: August 01, 2023

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare


IAS 2021

ProCE Banner